Astera Labs Announces Financial Results for the First Quarter of Fiscal Year 2024

Astera Labs宣佈2024財年第一季度的財務業績

asteralabs · 06/30 23:30

SANTA CLARA, CA, U.S. – May 7, 2024 – Astera Labs (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for cloud and AI infrastructure, today announced preliminary financial results for the first quarter of fiscal 2024, ended March 31, 2024.

“Astera Labs started the year strong, achieving record revenue in the first quarter, driven by the accelerating deployment of AI infrastructure,” said Jitendra Mohan, Astera Labs’ Chief Executive Officer. “As hyperscalers embark on a significant transformation of their data centers to support AI applications with increased capital investment, we’re witnessing the emergence of a multi-year growth cycle. Our Intelligent Connectivity Platform, comprising of the COSMOS software suite and semiconductor-based PCIe, Ethernet, and CXL solutions, is uniquely positioned to support this growth and is foundational to deploying AI infrastructure at scale. In the first quarter, we further extended our connectivity platform and started sampling our third generation of Aries Retimers with support for PCIe 6.x and the industry’s first PCIe/CXL Smart Cable Modules for Active Electrical Cable applications to enable multi-rack GPU clustering.”

Q1 Financial Highlights

GAAP Financial Results:

Revenue of $65.3 million, up 29% sequentially and up 269% year-over-year
GAAP gross margin of 77.4%
GAAP operating loss of $83.0 million
GAAP net loss of $93.0 million
GAAP basic and diluted net loss per share attributable to common stockholders of ($1.77) on weighted-average shares outstanding of 52.5 million

Non-GAAP Financial Results (excluding the impact of stock compensation, employer payroll tax related to stock-based compensation from our IPO, income tax effects of non-GAAP adjustments, and certain other items):

Non-GAAP gross margin of 78.2%
Non-GAAP operating income of $15.9 million
Non-GAAP net income of $14.3 million
Pro forma non-GAAP diluted earnings per share of $0.10

Q1 and Recent Business Highlights

Expanded the widely deployed and field-tested Aries PCIe/CXL Smart DSP Retimer portfolio with the sampling of Aries 6 Retimers, the industry’s lowest power PCIe 6.x/CXL 3.x Retimer solution, to achieve higher bandwidth and extended reach across complex AI and compute topologies. Through collaboration with the industry’s leading GPU and CPU providers such as AMD, Arm, Intel, and NVIDIA, Aries 6 is being rigorously tested at Astera Labs’ Cloud-Scale Interop Lab and in customer platforms to minimize interoperation risk, lower system development costs, and reduce time to market. Aries 6 was demonstrated at NVIDIA GTC during the week of March 18th.
Announced sampling of Aries PCIe/CXL Smart Cable Modules for Active Electrical Cable applications to enable multi-rack GPU clustering and low-latency memory fabric connectivity within AI infrastructure. The solution drives an industry-leading seven meters of channel reach over flexible copper cables to seamlessly interconnect clusters of GPUs across rack enclosures.
Announced the pricing and closing of an initial public offering of 22,770,000 shares of Astera Labs common stock at a price to the public of $36.00 per share. Net proceeds to Astera Labs from the offering were $672.2 million after deducting underwriting discounts and commissions. The shares began trading on the NASDAQ Global Select Market under the ticker symbol “ALAB” on March 20, 2024.

Second Quarter Fiscal 2024 Financial Outlook

Based on current business trends and conditions, Q2 revenue is expected to increase within a range of 10% to 12% compared with the prior quarter. We also estimate the following:

GAAP Financial Outlook:

GAAP gross margin of approximately 77%
GAAP operating expenses of approximately $79 million
GAAP interest income of approximately $9 million
GAAP tax rate of approximately (20%)
GAAP diluted loss per share of approximately ($0.11) on weighted-average diluted shares outstanding of approximately 155 million

Non-GAAP Financial Outlook (excluding the impact of approximately $39 million of stock-based compensation and including $3 million of additional income taxes):

Non-GAAP gross margin of approximately 77%
Non-GAAP operating expenses of approximately $40 million
Non-GAAP tax rate of approximately 23%
Non-GAAP diluted earnings per share of approximately $0.11 on weighted-average diluted shares outstanding of approximately 180 million
ASTERA LABS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(In thousands)

	March 31, 2024	December 31, 2023
Assets
Current assets
Cash and cash equivalents	$ 696,077	$ 45,098
Marketable securities	105,314	104,215
Accounts receivable, net	16,757	8,335
Inventory	29,567	24,095
Prepaid expenses and other current assets	6,725	4,064
Total current assets	854,440	185,807
Property and equipment, net	7,581	4,712
Other assets	2,880	5,773
Total assets	$ 864,901	$ 196,292

Liabilities, Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit)
Current liabilities
Accounts payable	$ 11,465	$ 6,337
Accrued expenses and other current liabilities	34,122	28,742
Total current liabilities	45,587	35,079
Other liabilities	10,530	3,787
Total liabilities	56,117	38,866
Commitments and contingencies
Redeemable convertible preferred stock	—	255,127
Stockholders’ equity (deficit)
Common stock	16	4
Additional paid-in capital	1,027,197	27,411
Accumulated other comprehensive (loss) income	(59)	259
Accumulated deficit	(218,370)	(125,375)
Total stockholders’ equity (deficit)	808,784	(97,701)
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)	$ 864,901	$ 196,292

ASTERA LABS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(In thousands, except per share amounts)

	Three Months Ended
	March 31, 2024	December 31, 2023	March 31, 2023
Revenue	$ 65,258	$ 50,514	$ 17,664
Cost of revenue	14,738	11,489	13,406
Gross profit	50,520	39,025	4,258

Operating expenses
Research and development	53,558	19,654	15,267
Sales and marketing	55,510	4,995	4,393
General and administrative	24,419	5,356	3,525
Total operating expenses	133,487	30,005	23,185
Operating (loss) income	(82,967)	9,020	(18,927)
Interest income	2,554	1,674	1,596
(Loss) Income before income taxes	(80,413)	10,694	(17,331)
Income tax provision (benefit)	12,582	(3,631)	123
Net (loss) income	$ (92,995)	$ 14,325	$ (17,454)

Net (loss) income per share attributable to common stockholders:
Basic and diluted	$ (1.77)	$ —	$ (0.49)
Weighted-average shares used in calculating net (loss) income per share attributable to common stockholders:
Basic	52,532	38,627	35,826
Diluted	52,532	47,636	35,826

ASTERA LABS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(In thousands)

	Three Months Ended
	March 31, 2024	March 31, 2023
Cash flows from operating activities
Net loss	$ (92,995)	$ (17,454)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities
Stock-based compensation	97,768	1,997
Inventory write-down	428	9,733
Depreciation	614	357
Non-cash operating lease expense	522	217
Warrants contra revenue	110	55
Accretion of discounts on marketable securities	(566)	(411)
Changes in operating assets and liabilities:
Accounts receivable, net	(8,422)	7,048
Inventory	(5,900)	458
Prepaid expenses and other assets	(2,666)	(411)
Accounts payable	4,973	(5,740)
Accrued expenses and other liabilities	10,224	563
Operating lease liability	(438)	(231)
Net cash provided by (used in) operating activities	3,652	(3,819)

Cash flows from investing activities
Purchases of property and equipment	(3,424)	(439)
Purchases of marketable securities	(23,308)	(22,346)
Maturities of marketable securities	9,365	13,000
Sales of marketable securities	13,116	45,082
Net cash (used in) provided by investing activities	(4,251)	35,297

Cash flows from financing activities
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions	672,198	—
Payment of deferred offering costs	(1,756)	—
Proceeds from exercises of stock options, net of repurchases	1,247	31
Tax withholding related to net share settlements of restricted stock units	(20,111)	—
Net cash provided by financing activities	651,578	31
Net increase in cash and cash equivalents	650,979	31,509
Cash and cash equivalents
Beginning of the period	45,098	76,088
End of the period	$ 696,077	$ 107,597

ASTERA LABS, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (Unaudited)

(In thousands, except percentages and per share amounts)

	Three Months Ended
	March 31, 2024	December 31, 2023	March 31, 2023
GAAP gross profit	$ 50,520	$ 39,025	$ 4,258
Stock-based compensation expense upon IPO (1)	516	—	—
Stock-based compensation expense	12	8	5
Non-GAAP gross profit	$ 51,048	$ 39,033	$ 4,263

GAAP gross margin	77.4 %	77.3 %	24.1 %
Stock-based compensation expense upon IPO (1)	0.8 %	—	—
Non-GAAP gross margin	78.2 %	77.3 %	24.1 %

GAAP operating (loss) income	$ (82,967)	$ 9,020	$ (18,927)
Stock-based compensation expense upon IPO (1)	88,873	—	—
Stock-based compensation expense	8,895	3,299	1,997
Employer payroll tax related to stock-based compensation from IPO (2)	1,072	—	—
Non-GAAP operating income (loss)	$ 15,873	$ 12,319	$ (16,930)

GAAP net (loss) income	$ (92,995)	$ 14,325	$ (17,454)
Stock-based compensation expense upon IPO (1)	88,873	—	—
Stock-based compensation expense	8,895	3,299	1,997
Employer payroll tax related to stock-based compensation from IPO (2)	1,072	—	—
Income tax effect (3)	8,485	—	—
Non-GAAP net income (loss)	$ 14,330	$ 17,624	$ (15,457)

Net (loss) income per share attributable to common stockholders:
GAAP – basic and diluted (4)	$ (1.77)	$ —	$ (0.49)
Pro forma Non-GAAP – diluted	$ 0.10	$ 0.12	$ (0.12)

Weighted-average shares used to compute net (loss) income per share attributable to common stockholders:
GAAP – basic	52,532	38,627	35,826
GAAP – diluted	52,532	47,636	35,826
Pro forma Non-GAAP – diluted (5)	147,514	138,527	126,717

____________________

(1) Stock-based compensation expense recognized in connection with the vesting and settlement of RSUs that had previously met the time vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO.

(2) Employer payroll taxes related to the vesting and settlement of RSUs, that had previously met the time vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO.

(3) For the three months ended March 31, 2024, the non-GAAP tax rate of approximately 22% is calculated based on the tax laws in the jurisdictions in which we operate and exclude the impact of stock-based compensation expense and associated employer payroll taxes. The adjustments for the three months ended December 31, 2023 and March 31, 2023 were not material.

(4) GAAP basic and diluted net income per share attributable to common stockholders for the three months ended December 31, 2023 was zero as all net income was attributable to preferred stockholders.

(5) Reconciliation of GAAP weighted-average shares to pro forma Non-GAAP weighted-average shares. We present the pro-forma non-GAAP weighted-average shares to provide meaningful supplemental information of comparable shares for each periods presented. The pro forma weighted-average shares is calculated as follows:

	Three Months Ended
	March 31, 2024	December 31, 2023	March 31, 2023
Shares used to compute GAAP net (loss) income per share attributable to common stockholders – diluted	52,532	47,636	35,826
Weighted-average effect of the assumed conversion of redeemable convertible preferred stock from the beginning of the quarter	78,905	90,891	90,891
Effect of potentially dilutive equivalent shares	16,077	—	—
Shares used to compute pro forma non-GAAP net income (loss) per share- diluted	147,514	138,527	126,717

ASTERA LABS, INC.

SUPPLEMENTAL FINANCIAL INFORMATION

STOCK-BASED COMPENSATION EXPENSE (Unaudited)

(In thousands)

	Three Months Ended
	March 31, 2024	December 31, 2023	March 31, 2023
Cost of revenue	$ 528	$ 8	$ 5
Research and development	30,007	2,303	1,679
Sales and marketing	49,258	681	1
General and administrative	17,975	307	312
Total stock-based compensation expense (1)	$ 97,768	$ 3,299	$ 1,997

____________________

(1) Stock-based compensation expense recognized during the three months ended March 31, 2024 included $88.9 million cumulative stock-based compensation expense related to the vesting and settlement of restricted stock units that had previously met the time vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO.

美國加州聖克拉拉 - 2024年5月7日 - Astera Labs（納斯達克：ALAB）是雲計算和人工智能基礎設施的半導體連接解決方案的全球領導者，今天宣佈了截至2024財年第一季度財務業績的初步財務結果，該季度截至2024年3月31日。

Astera Labs首席執行官Jitendra Mohan表示：“Astera Labs在本財年第一季度取得了強勁的業績，在AI基礎設施加速部署的驅動下實現了創紀錄的財務收入，隨着超大規模企業開始在數據中心加大資本投入，以支持人工智能應用程序的重大轉型，我們正在目睹多年的增長週期的出現。我們的智能連接平台包括COSMOS軟件套件和基於半導體的PCIe，以太網和CXL解決方案，具有獨特的市場地位，可支持此增長，併爲大規模部署AI基礎設施提供基礎。第一季度，我們進一步擴展了我們的連接平台，並開始抽樣我們第三代的Aries Retimers，支持PCIe 6.x和行業首款支持PCIe/CXL的智能電纜模塊，以啓用多機架GPU聚類。

Q1 Financial Highlights

Q1財務亮點

GAAP Financial Results:

根據通用會計準則的財務結果：

Revenue of $65.3 million, up 29% sequentially and up 269% year-over-year
GAAP gross margin of 77.4%
GAAP operating loss of $83.0 million
GAAP net loss of $93.0 million
GAAP basic and diluted net loss per share attributable to common stockholders of ($1.77) on weighted-average shares outstanding of 52.5 million

營業收入6530萬美元，環比增長29%，同比增長269%
通用會計準則的毛利率爲77.4%
通用會計準則的運營虧損爲8300萬美元
通用會計準則的淨虧損爲9300萬美元
基礎和稀釋後每股普通股股東淨虧損爲1.77美元，基礎加權平均股數爲5250萬股

非通用會計準則的財務結果（排除股票補償、IPO相關的僱主薪資稅、非通用會計調整的所得稅影響以及某些其他項目）：

Non-GAAP gross margin of 78.2%
Non-GAAP operating income of $15.9 million
Non-GAAP net income of $14.3 million
Pro forma non-GAAP diluted earnings per share of $0.10

非通用會計準則的毛利率爲78.2%
非通用會計準則的營業收入爲1590萬美元
非通用會計準則的淨收入爲1430萬美元
Pro forma非通用會計準則稀釋每股收益爲0.10美元

Q1 and Recent Business Highlights

Q1和最近的業務亮點

Expanded the widely deployed and field-tested Aries PCIe/CXL Smart DSP Retimer portfolio with the sampling of Aries 6 Retimers, the industry’s lowest power PCIe 6.x/CXL 3.x Retimer solution, to achieve higher bandwidth and extended reach across complex AI and compute topologies. Through collaboration with the industry’s leading GPU and CPU providers such as AMD, Arm, Intel, and NVIDIA, Aries 6 is being rigorously tested at Astera Labs’ Cloud-Scale Interop Lab and in customer platforms to minimize interoperation risk, lower system development costs, and reduce time to market. Aries 6 was demonstrated at NVIDIA GTC during the week of March 18th.
Announced sampling of Aries PCIe/CXL Smart Cable Modules for Active Electrical Cable applications to enable multi-rack GPU clustering and low-latency memory fabric connectivity within AI infrastructure. The solution drives an industry-leading seven meters of channel reach over flexible copper cables to seamlessly interconnect clusters of GPUs across rack enclosures.
Announced the pricing and closing of an initial public offering of 22,770,000 shares of Astera Labs common stock at a price to the public of $36.00 per share. Net proceeds to Astera Labs from the offering were $672.2 million after deducting underwriting discounts and commissions. The shares began trading on the NASDAQ Global Select Market under the ticker symbol “ALAB” on March 20, 2024.

通過抽樣Aries 6 Retimers，行業內功耗最低的PCIe 6.x/CXL 3.x Retimer解決方案，爲複雜的AI和計算拓撲結構提供更高帶寬和擴展範圍，擴展了廣泛部署和經過現場測試的Aries PCIe/CXL Smart DSP Retimer組合。通過與AMD、Arm、Intel和NVIDIA等行業領先的GPU和CPU供應商的合作，Aries 6正在Astera Labs的雲級互操作性實驗室和客戶平台中進行嚴格測試，以最小化互操作風險、降低系統開發成本和縮短產品上市時間。Aries 6已在3月18日的NVIDIA GTC展會上進行了演示。
宣佈Aries PCIe/CXL智能電纜模塊的抽樣，用於啓用多機架GPU聚類和低延遲內存基礎設施連接。該解決方案通過靈活的銅質電纜驅動7米的信道距離，無縫連接機架之間的GPU群。
宣佈了Astera Labs普通股的首次公開發行於2024年3月20日開始在納斯達克全球精選市場上交易，股票代碼爲“ALAB”，普通股發行數量爲22,770,000股，發行價格爲每股36.00美元。扣除承銷折扣和佣金後，Astera Labs從發行中獲得的淨收益爲6.722億美元。

Second Quarter Fiscal 2024 Financial Outlook

2024財年第二季度財務前景

Based on current business trends and conditions, Q2 revenue is expected to increase within a range of 10% to 12% compared with the prior quarter. We also estimate the following:

根據當前的業務趨勢和狀況，預計Q2收入將較上季度增長10%至12%。我們還預計以下情況：

GAAP Financial Outlook:

GAAP財務展望：

GAAP gross margin of approximately 77%
GAAP operating expenses of approximately $79 million
GAAP interest income of approximately $9 million
GAAP tax rate of approximately (20%)
GAAP diluted loss per share of approximately ($0.11) on weighted-average diluted shares outstanding of approximately 155 million

GAAP毛利率約爲77%
GAAP營業費用約爲7900萬美元
GAAP利息收入約爲900萬美元
GAAP稅率約爲（20%）
GAAP加權平均攤薄股份約爲1.55億股，每股攤薄虧損約爲0.11美元

Non-GAAP Financial Outlook (excluding the impact of approximately $39 million of stock-based compensation and including $3 million of additional income taxes):

非GAAP財務展望（不包括約3900萬美元的股權酬勞影響，包括300萬美元的額外所得稅）：

Non-GAAP gross margin of approximately 77%
Non-GAAP operating expenses of approximately $40 million
Non-GAAP tax rate of approximately 23%
Non-GAAP diluted earnings per share of approximately $0.11 on weighted-average diluted shares outstanding of approximately 180 million

ASTERA LABS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(In thousands)

非GAAP毛利率約爲77%
非GAAP營業費用約爲4000萬美元
非GAAP稅率約爲23%
非GAAP加權平均攤薄股份約爲1.8億股，每股攤薄收益約爲0.11美元

ASTERA LABS, INC.

基本報表資產負債表（未經審計）

（以千爲單位）

	March 31, 2024	December 31, 2023
Assets
Current assets
Cash and cash equivalents	$ 696,077	$ 45,098
Marketable securities	105,314	104,215
Accounts receivable, net	16,757	8,335
Inventory	29,567	24,095
Prepaid expenses and other current assets	6,725	4,064
Total current assets	854,440	185,807
Property and equipment, net	7,581	4,712
Other assets	2,880	5,773
Total assets	$ 864,901	$ 196,292

Liabilities, Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit)
Current liabilities
Accounts payable	$ 11,465	$ 6,337
Accrued expenses and other current liabilities	34,122	28,742
Total current liabilities	45,587	35,079
Other liabilities	10,530	3,787
Total liabilities	56,117	38,866
Commitments and contingencies
Redeemable convertible preferred stock	—	255,127
Stockholders’ equity (deficit)
Common stock	16	4
Additional paid-in capital	1,027,197	27,411
Accumulated other comprehensive (loss) income	(59)	259
Accumulated deficit	(218,370)	(125,375)
Total stockholders’ equity (deficit)	808,784	(97,701)
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)	$ 864,901	$ 196,292

	3月31日 2024	12月31日 2023
資產
流動資產
現金及現金等價物	$ 696,077	$ 45,098
有價證券	105,314	104,215
應收賬款淨額	16,757	8,335
庫存	29,567	24,095
資產預付款和其他流動資產的變動	6,725	4,064
總流動資產	854,440	185,807
資產和設備，淨值	7,581	4,712
其他	2,880	5,773
總資產	$ 864,901	$ 196,292

負債，可轉換優先股和股東權益（赤字）
流動負債
應付賬款	$11,465	$6,337
應計費用及其他流動負債	34,122	28,742
流動負債合計	45,587	35,079
其他負債	10,530	3,787
負債合計	56,117	38,866
承諾和 contingencies
可轉換優先股	—	255,127
股東權益（赤字）
普通股	16	4
額外實收資本	1,027,197	27,411
已實現其他綜合收益 (損失)	(59)	259
累積赤字	(218,370)	(125,375)
股東權益（赤字）	808,784	(97,701)
總負債、可贖回優先股和股東權益（赤字）	$ 864,901	$ 196,292

ASTERA LABS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

基本財務報表(未經審計)

(In thousands, except per share amounts)

2024年4月27日

	Three Months Ended
	March 31, 2024	December 31, 2023	March 31, 2023
Revenue	$ 65,258	$ 50,514	$ 17,664
Cost of revenue	14,738	11,489	13,406
Gross profit	50,520	39,025	4,258

Operating expenses
Research and development	53,558	19,654	15,267
Sales and marketing	55,510	4,995	4,393
General and administrative	24,419	5,356	3,525
Total operating expenses	133,487	30,005	23,185
Operating (loss) income	(82,967)	9,020	(18,927)
Interest income	2,554	1,674	1,596
(Loss) Income before income taxes	(80,413)	10,694	(17,331)
Income tax provision (benefit)	12,582	(3,631)	123
Net (loss) income	$ (92,995)	$ 14,325	$ (17,454)

Net (loss) income per share attributable to common stockholders:
Basic and diluted	$ (1.77)	$ —	$ (0.49)
Weighted-average shares used in calculating net (loss) income per share attributable to common stockholders:
Basic	52,532	38,627	35,826
Diluted	52,532	47,636	35,826

	三個月之內結束
	3月31日 2024	12月31日 2023	3月31日 2023
營業收入	$ 65,258	$ 50,514	$ 17,664
營業收入成本	14,738	11,489	13,406
毛利潤	50,520	39,025	4,258

營業費用
研發	53,558	19,654	15,267
銷售及營銷費用	55,510	4,995	4,393
普通和管理	24,419	5,356	3,525
營業費用總計	133,487	30,005	23,185
營業（虧損）收入	(82,967)	9,020	(18,927)
利息收入	2,554	1,674	1,596
(損失)稅前收入	(80,413)	10,694	(17,331)
所得稅負擔（利益）	12,582	(3,631)	123
淨（虧損）利潤	（92,995）美元	$ 14,325	（17,454）美元

每股淨(虧損)收益歸屬於普通股股東：
基本和稀釋	$ (1.77)	$ —	$ (0.49)
計算每股歸屬於普通股股東的淨(虧損)收益所使用的加權平均股數:
基本	52,532	38,627	35,826
攤薄	52,532	47636	35,826

ASTERA LABS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

簡化的現金流量表（未經審計）

(In thousands)

（以千爲單位）

	Three Months Ended
	March 31, 2024	March 31, 2023
Cash flows from operating activities
Net loss	$ (92,995)	$ (17,454)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities
Stock-based compensation	97,768	1,997
Inventory write-down	428	9,733
Depreciation	614	357
Non-cash operating lease expense	522	217
Warrants contra revenue	110	55
Accretion of discounts on marketable securities	(566)	(411)
Changes in operating assets and liabilities:
Accounts receivable, net	(8,422)	7,048
Inventory	(5,900)	458
Prepaid expenses and other assets	(2,666)	(411)
Accounts payable	4,973	(5,740)
Accrued expenses and other liabilities	10,224	563
Operating lease liability	(438)	(231)
Net cash provided by (used in) operating activities	3,652	(3,819)

Cash flows from investing activities
Purchases of property and equipment	(3,424)	(439)
Purchases of marketable securities	(23,308)	(22,346)
Maturities of marketable securities	9,365	13,000
Sales of marketable securities	13,116	45,082
Net cash (used in) provided by investing activities	(4,251)	35,297

Cash flows from financing activities
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions	672,198	—
Payment of deferred offering costs	(1,756)	—
Proceeds from exercises of stock options, net of repurchases	1,247	31
Tax withholding related to net share settlements of restricted stock units	(20,111)	—
Net cash provided by financing activities	651,578	31
Net increase in cash and cash equivalents	650,979	31,509
Cash and cash equivalents
Beginning of the period	45,098	76,088
End of the period	$ 696,077	$ 107,597

	三個月之內結束
	3月31日 2024	3月31日 2023
經營活動現金流
淨虧損	（92,995）美元	（17,454）美元
調整以將淨虧損調節爲經營活動中提供的現金淨額
以股票爲基礎的報酬計劃	97,768	1,997
存貨減值	428	9,733
折舊費用	614	357
非現金租賃費用	522	217
Warrants contra revenue	110	55
Accretion of discounts on marketable securities	（566）	(411)
經營性資產和負債變動:
應收賬款淨額	（8,422）	7,048
庫存	(5,900)	458
預付款項和其他資產	(2,666)	(411)
應付賬款	4,973	(5,740)
應計費用及其他負債	10,224	563
經營租賃負債	(438)	(231)
經營活動產生的淨現金流量	3,652	(3,819)

投資活動現金流量
購買固定資產	(3,424)	(439)
購買有市場流通的證券	(23,308)	(22,346)
有價證券到期收益	9,365	13,000
可變市場證券銷售	13,116	45,082
投資活動的淨現金流量(使用)/提供的淨現金流量	(4,251)	35,297

籌資活動現金流量
發行普通股與初始公開發行相關的淨額，扣除承銷折扣和佣金	672,198	—
支付推遲發行成本	(1,756)	—
行使股票期權後回購的淨額	1,247	31
與受限制股票單位淨份額結算相關的稅款代扣	(20,111)	—
籌資活動產生的現金淨額	651,578	31
現金及現金等價物淨增加額	650,979	31,509
現金及現金等價物
期初	45,098	76,088
期末	$ 696,077	$ 107,597

ASTERA LABS, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (Unaudited)

GAAP和非GAAP財務衡量的調解（未經審計）

(In thousands, except percentages and per share amounts)

（以千爲單位，除百分比和每股金額外）

	Three Months Ended
	March 31, 2024	December 31, 2023	March 31, 2023
GAAP gross profit	$ 50,520	$ 39,025	$ 4,258
Stock-based compensation expense upon IPO (1)	516	—	—
Stock-based compensation expense	12	8	5
Non-GAAP gross profit	$ 51,048	$ 39,033	$ 4,263

GAAP gross margin	77.4 %	77.3 %	24.1 %
Stock-based compensation expense upon IPO (1)	0.8 %	—	—
Non-GAAP gross margin	78.2 %	77.3 %	24.1 %

GAAP operating (loss) income	$ (82,967)	$ 9,020	$ (18,927)
Stock-based compensation expense upon IPO (1)	88,873	—	—
Stock-based compensation expense	8,895	3,299	1,997
Employer payroll tax related to stock-based compensation from IPO (2)	1,072	—	—
Non-GAAP operating income (loss)	$ 15,873	$ 12,319	$ (16,930)

GAAP net (loss) income	$ (92,995)	$ 14,325	$ (17,454)
Stock-based compensation expense upon IPO (1)	88,873	—	—
Stock-based compensation expense	8,895	3,299	1,997
Employer payroll tax related to stock-based compensation from IPO (2)	1,072	—	—
Income tax effect (3)	8,485	—	—
Non-GAAP net income (loss)	$ 14,330	$ 17,624	$ (15,457)

Net (loss) income per share attributable to common stockholders:
GAAP – basic and diluted (4)	$ (1.77)	$ —	$ (0.49)
Pro forma Non-GAAP – diluted	$ 0.10	$ 0.12	$ (0.12)

Weighted-average shares used to compute net (loss) income per share attributable to common stockholders:
GAAP – basic	52,532	38,627	35,826
GAAP – diluted	52,532	47,636	35,826
Pro forma Non-GAAP – diluted (5)	147,514	138,527	126,717

	三個月之內結束
	3月31日 2024	12月31日 2023	3月31日 2023
GAAP毛利潤	$ 50,520	$ 39,025	$ 4,258
IPO股票授予激勵支出(1)	516	—	—
股票補償費用	12	8	5
非通用會計原則毛利潤	$ 51,048	$ 39,033	$ 4,263

GAAP毛利率	77.4 %	77.3 %	24.1 %
IPO股票授予激勵支出(1)	0.8%	—	—
非GAAP毛利率	78.2 %	77.3 %	24.1 %

GAAP營業（虧損）收入	$ (82,967)	$ 9,020	$ (18,927)
IPO股票授予激勵支出(1)	88,873	—	—
股票補償費用	8,895	3,299	1,997
與IPO相關的僱主薪酬稅(2)	1,072	—	—
非通用會計原則下的營業收入（虧損）	$ 15,873	$ 12,319	$ (16,930)

按照通用會計準則，淨（虧損）收益	$ (92,995)	$ 14,325	$ (17,454)
IPO股票授予激勵支出(1)	88,873	—	—
股票補償費用	8,895	3,299	1,997
與IPO相關的僱主薪酬稅(2)	1,072	—	—
所得稅影響（3）	8,485	—	—
非GAAP淨收入（淨虧損）	$ 14,330	$ 17,624	$ (15,457)

每股淨(虧損)收益歸屬於普通股股東：
GAAP - 基本和稀釋(4)	$ (1.77)	$ —	$ (0.49)
非GAAP勾選 - 稀釋	$ 0.10	$ 0.12	$ (0.12)

計算淨(虧損)收益每股歸屬於普通股股東的加權平均股數：
GAAP - 基本	52,532	38,627	35826
GAAP - 稀釋	52,532	47,636	35826
Pro forma Non-GAAP – diluted (5)	147514	138527	126717

____________________

（1）在IPO時，滿足時間限制以及流動性事件限制的RSU的歸屬股日期，以及與之相關的股票補償費用。

（2）與IPO相關的RSU的授予和行權，僱主的工資稅。

（3）截至2024年3月31日的三個月，非GAAP稅率約爲22％，根據我們運營地區的稅法計算，並排除股票補償費用和相關的僱主工資稅影響。 2023年12月31日和2023年3月31日的調整不重要。

(4) GAAP basic and diluted net income per share attributable to common stockholders for the three months ended December 31, 2023 was zero as all net income was attributable to preferred stockholders.

截至2023年12月31日的三個月，按照GAAP基本和攤薄的每股淨收益歸屬於普通股股東爲零，因爲所有淨收益均歸屬於優先股股東。

調和GAAP加權平均股份至調整後的非GAAP加權平均股份。我們提供調整後的非GAAP加權平均股份，以提供獨立於股份類別的可比份額的有意義的補充信息。以下是調整後的加權平均股份的計算方法：

	Three Months Ended
	March 31, 2024	December 31, 2023	March 31, 2023
Shares used to compute GAAP net (loss) income per share attributable to common stockholders – diluted	52,532	47,636	35,826
Weighted-average effect of the assumed conversion of redeemable convertible preferred stock from the beginning of the quarter	78,905	90,891	90,891
Effect of potentially dilutive equivalent shares	16,077	—	—
Shares used to compute pro forma non-GAAP net income (loss) per share- diluted	147,514	138,527	126,717

	三個月之內結束
	3月31日 2024	12月31日 2023	3月31日 2023
用於計算基本和攤薄的每股GAAP淨（損）收益歸屬於普通股股東的股份 - 攤薄	52532	47636	35826
從本季度開始的可贖回可轉換優先股的假定轉換影響的加權影響股份	78905	90891	90891
潛在稀釋等效股影響	16077	—	—
用於計算攤薄後的非通用會計淨利潤（虧損）的股份	147,514	138,527	126,717

ASTERA LABS, INC.

SUPPLEMENTAL FINANCIAL INFORMATION

補充財務信息

STOCK-BASED COMPENSATION EXPENSE (Unaudited)

股份補償費用（未經審計）

(In thousands)

（以千爲單位）

	Three Months Ended
	March 31, 2024	December 31, 2023	March 31, 2023
Cost of revenue	$ 528	$ 8	$ 5
Research and development	30,007	2,303	1,679
Sales and marketing	49,258	681	1
General and administrative	17,975	307	312
Total stock-based compensation expense (1)	$ 97,768	$ 3,299	$ 1,997

	三個月之內結束
	3月31日 2024	12月31日 2023	3月31日 2023
營業收入成本	$ 528	$ 8	$ 5
研發	30,007	2,303	1,679
銷售及營銷費用	49,258	681	1
普通和管理	17,975	307	312
總股份爲基礎的補償費用(1)	$97,768	$3,299	$1,997

____________________

(1) 控件週期內股份補償費用共計88.9百萬美元，與公司首次公開發行(IPO)相關的限制性股票單元(已達到時間限制條件並滿足流動性事件限制條件)解除限制和結算。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

Astera Labs Announces Financial Results for the First Quarter of Fiscal Year 2024

Astera Labs Announces Financial Results for the First Quarter of Fiscal Year 2024

風險及免責聲明

聲明